Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Antibe Therapeutics Inc(Pre-Merger) ATBPF

Antibe Therapeutics Inc. is a clinical-stage biotechnology company. The Company is leveraging its hydrogen sulfide (H2S) platform to develop therapies to target inflammation arising from a range of medical conditions. The Company’s pipeline includes assets that seek to overcome the gastrointestinal ulcers and bleeding associated with nonsteroidal anti-inflammatory drugs (NSAIDs). Its lead drug, otenaproxesul, is in clinical development as an alternative to opioids and NSAIDs for acute pain. Its second pipeline drug, ATB-352, is being developed for a specialized pain indication. The Company also focuses on inflammatory bowel disease (IBD). Otenaproxesul combines a moiety that releases hydrogen sulfide with naproxen, a non-steroidal, anti-inflammatory drug. ATB-352 is an H2S-releasing derivative of ketoprofen, a potent NSAID commonly prescribed for acute pain. Its IBD candidates are being designed to maintain the efficacy, safety, and pharmacokinetic properties of ATB-429.


GREY:ATBPF - Post by User

Comment by Rarbar99on Aug 20, 2021 10:32am
96 Views
Post# 33739423

RE:RE:RE:RE:RE:RE:RE:RE:RE:RE:I apologize

RE:RE:RE:RE:RE:RE:RE:RE:RE:RE:I apologize

first you didn't believe I was a shareholder, so I showed you my car that costs 10x as much as my investment into this company and now you don't believe that's my car? So I just happened to stumble upon a brand new G63 as we were arguing, right? I regret posting that picture because it was in bad faith, not because of you, but because of all the other people here who lost a big chunk of their money last month. I do not want to offend them, my only intention was to offend you. And it worked. You immediately stopped talking and only came back several hours later and tried to act like I didn't ask you to show me yours. Now stop messaging me dude, I don't care what you have to say. I'll let that G63 talk for me.


Inthepez wrote: Ok incel. Too much emotion is an incel pretending he owns a car that he didn’t pay for because random people on stockhouse trolled him. But you’re likely too stup!d to appreciate the irony lol!

The drug is too powerful. That’s never a bad thing. the value of Otena is there, it’s only delays at this point, so monetization will be delayed. 

Thanks for the lols incel 
 

Rarbar99 wrote:

Your problem is that you have too much emotion. As soon as you spot a bear you start getting angry and personal with them. This is why you’re a failed investor. You need to let that emotion go and just relax, it’s not that serious. You're like a little child who's angry I stole his toy.





<< Previous
Bullboard Posts
Next >>